Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : Tokyo Joe's Cafe / Societe Anonyme/No Pennies -- Ignore unavailable to you. Want to Upgrade?

To: Rocket Red who wrote (49007)	1/28/1999 6:22:00 PM
From: Mr. Big	Read Replies (3) \| Respond to of 119973

Mr. Big is back and luckily got some SCIO - Michael Murphy likes it as well! Michael Murphy of the California Tech Stock Newsletter mentioned Scios as one of the stocks that he expects to get FDA approval at the meeting next week (January 29th). (on CNBC last Friday) A report by SG Cowen Securities Corp. said Natrecor has more than a 50% chance of getting support from Friday's panel. Scios has an agreement for Bayer AG (BAYZY) to market Natrecor world-wide. According to a Scios release, in the U.S., congestive heart failure accounts for almost $20 billion in health-care costs yearly and 1 million hospital admissions. About 400,000 new cases are diagnosed annually.